4.9.1: Dopaminergic drugs used in parkinsonism

Part of chapter 4 Central Nervous System, section 4.9 Drugs used in parkinsonism and related disorders

High-level prescribing trends for Dopaminergic drugs used in parkinsonism (BNF section 4.9.1) across Cityview PCN for the last five years. You can explore prescribing trends for this section by Sub-ICB Location, or learn more about this site.

View all matching dm+d items.

No prescriptions found.

Do you need help with your analysis? Don't forget to check the FAQ page, and get in touch if you have questions.

Chemicals

Amantadine hydrochloride (0409010B0)
Apomorphine hydrochloride (0409010A0)
Apomorphine hydrochloride hemihydrate (0409010AC)
Cabergoline (0409010U0)
Carbidopa (0409010D0)
Co-beneldopa (Benserazide/levodopa) (0409010K0)
Co-careldopa (Carbidopa/levodopa) (0409010N0)
Entacapone (0409010V0)
Levodopa (0409010I0)
Levodopa/carbidopa/entacapone (0409010X0)
Memantine Hydrochloride (0409010M0)
Opicapone (0409010AB)
Pergolide mesilate (0409010P0)
Pramipexole (0409010W0)
Rasagiline mesilate (0409010Y0)
Ropinirole hydrochloride (0409010H0)
Rotigotine (0409010Z0)
Safinamide (0409010AA)
Selegiline hydrochloride (0409010T0)
Tolcapone (0409010S0)
Feedback